S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CHRS Coherus BioSciences Inc

1.47

0.04 (2.80%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences Inc News

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Wednesday 18 December 2024 (7 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 4 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

California-Based Biotech Rallies Strongly Following $558.4M Divestiture
Tuesday 3 December 2024 (3 weeks ago) • AllPennyStocks.com

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
Tuesday 3 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Wednesday 27 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

More Coherus BioSciences Inc News Articles

Js Real Estate Multigest...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions